Single-cell transcriptomics in thyroid eye disease

Area of Science:

• Ophthalmology
• Immunology
• Genomics

Background:

• Thyroid Eye Disease (TED) is an autoimmune disorder impacting retroorbital tissues, potentially causing vision loss and disfigurement.
• Current treatments for TED have limited efficacy, with significant relapse and non-response rates.
• The underlying cellular and molecular mechanisms of TED remain incompletely understood.

Purpose of the Study:

• To review recent advancements in understanding TED pathogenesis using single-cell transcriptomics.
• To highlight novel biomarkers and therapeutic targets identified through single-cell analysis.
• To discuss challenges and future applications of single-cell technologies in TED research.

Main Methods:

• Utilizing high-throughput single-cell RNA sequencing (scRNA-seq).
• Analyzing single-nucleus RNA sequencing (snRNA-seq) data.
• Reviewing current literature on transcriptomic studies in TED.

Main Results:

• scRNA-seq has elucidated diverse cell populations and molecular pathways involved in TED.
• Identification of potential novel biomarkers for TED diagnosis and prognosis.
• Discovery of new molecular targets for therapeutic intervention in TED.

Conclusions:

• Single-cell transcriptomics provides unprecedented resolution into TED pathogenesis.
• Emerging data offers opportunities for improved patient outcomes and disease reversal.
• Further application of these technologies is crucial for advancing TED management.